Hurdle jumping

How investors think biotech has weathered the last big milestones of 2016

With the biotech indices brushing off 2016’s latest major milestone, biotech now appears to be free of any events that could jolt the sector in the year’s waning weeks.

Investors had circled two major November events: the U.S. elections and data

Read the full 401 word article

User Sign In